Announcements
20 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Informatics and Big Data
We are delighted to share some highly viewed papers on cancer informatics and big data that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:
“Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer”
by John-Melle Bokhorst, Iris D. Nagtegaal, Inti Zlobec, Heather Dawson, Kieran Sheahan, Femke Simmer, Richard Kirsch, Michael Vieth, Alessandro Lugli, Jeroen van der Laak et al.
Cancers 2023, 15(7), 2079; https://doi.org/10.3390/cancers15072079
Available online: https://www.mdpi.com/2072-6694/15/7/2079
“The Role of AI in Breast Cancer Lymph Node Classification: A Comprehensive Review”
by Josip Vrdoljak, Ante Krešo, Marko Kumrić, Dinko Martinović, Ivan Cvitković, Marko Grahovac, Josip Vickov, Josipa Bukić and Joško Božic
Cancers 2023, 15(8), 2400; https://doi.org/10.3390/cancers15082400
Available online: https://www.mdpi.com/2072-6694/15/8/2400
“Multimodal Data Integration to Predict Severe Acute Oral Mucositis of Nasopharyngeal Carcinoma Patients Following Radiation Therapy”
by Yanjing Dong, Jiang Zhang, Saikt Lam, Xinyu Zhang, Anran Liu, Xinzhi Teng, Xinyang Han, Jin Cao, Hongxiang Li, Francis Karho Lee et al.
Cancers 2023, 15(7), 2032; https://doi.org/10.3390/cancers15072032
Available online: https://www.mdpi.com/2072-6694/15/7/2032
“NRK-ABMIL: Subtle Metastatic Deposits Detection for Predicting Lymph Node Metastasis in Breast Cancer Whole-Slide Images”
by Usama Sajjad, Mostafa Rezapour, Ziyu Su, Gary H. Tozbikian, Metin N. Gurcan and M. Khalid Khan Niazi
Cancers 2023, 15(13), 3428; https://doi.org/10.3390/cancers15133428
Available online: https://www.mdpi.com/2072-6694/15/13/3428
“Comparative Analysis of Three Predictive Models of Performance Indicators with Results-Based Management: Cancer Data Statistics in a National Institute of Health”
by Joel Martínez-Salazar and Filiberto Toledano-Toledano
Cancers 2023, 15(18), 4649; https://doi.org/10.3390/cancers15184649
Available online: https://www.mdpi.com/2072-6694/15/18/4649
“Identification of Novel Diagnostic and Prognostic Gene Signature Biomarkers for Breast Cancer Using Artificial Intelligence and Machine Learning Assisted Transcriptomics Analysis”
by Zeenat Mirza, Md Shahid Ansari, Md Shahid Iqbal, Nesar Ahmad, Nofe Alganmi, Haneen Banjar, Mohammed H. Al-Qahtani and Sajjad Karim
Cancers 2023, 15(12), 3237; https://doi.org/10.3390/cancers15123237
Available online: https://www.mdpi.com/2072-6694/15/12/3237
|
“Artificial Intelligence in Cancer Research: Knowledge Representation and Data Perspectives” Edited by Dr. Catia Pesquita and Dr. Andreas Schlicker
|
“Advances in Cancer Data and Statistics” Edited by Prof. Dr. Vesna Zadnik |
|
“Novel Approaches to Machine Learning and Artificial Intelligence in Cancer Research and Care” Edited by Dr. Caroline Chung and Dr. Christopher Gibbons
|
“Next Generation Sequencing for Cancer Diagnostics” Edited by Dr. Gayatry Mohapatra
|
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers
Cancers Editorial Office
19 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Clinical Research of Cancer
We are delighted to share some highly viewed papers on clinical research of cancer that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:
“Current Main Topics in Multiple Myeloma”
by Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Attilio Olivieri and Massimo Offidani
Cancers 2023, 15(8), 2203; https://doi.org/10.3390/cancers15082203
Available online: https://www.mdpi.com/2072-6694/15/8/2203
“Management of Advanced Prostate Cancer in the Precision Oncology Era”
by Claire M. Gillette, Gabriel A. Yette, Scott D. Cramer and Laura S. Graham
Cancers 2023, 15(9), 2552; https://doi.org/10.3390/cancers15092552
Available online: https://www.mdpi.com/2072-6694/15/9/2552
“Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors”
by Vladimir Chernov, Anastasiya Rybina, Roman Zelchan, Anna Medvedeva, Olga Bragina, Nadejda Lushnikova, Artem Doroshenko, Evgeniy Usynin, Liubov Tashireva, Sergey Vtorushin et al.
Cancers 2023, 15(6), 1631; https://doi.org/10.3390/cancers15061631
Available online: https://www.mdpi.com/2072-6694/15/6/1631
“Development of a Patient Decision Aid for Rectal Cancer Patients with Clinical Complete Response after Neo-Adjuvant Treatment”
by Lien Smets, Annelies Debucquoy, Eva Oldenburger, Chantal Van Audenhove, Lynn Debrun, Jeroen Dekervel, Gabriele Bislenghi, André D’Hoore, Albert Wolthuis and Karin Haustermans
Cancers 2023, 15(3), 806; https://doi.org/10.3390/cancers15030806
Available online: https://www.mdpi.com/2072-6694/15/3/806
“A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma”
by Nam Bui, Hilary Dietz, Sheima Farag, Angela C. Hirbe, Michael J. Wagner, Brian A. Van Tine, Kristen Ganjoo, Robin L. Jones, Vicki L. Keedy and Elizabeth J. Davis
Cancers 2023, 15(9), 2617; https://doi.org/10.3390/cancers15092617
Available online: https://www.mdpi.com/2072-6694/15/9/2617
“Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer”
by Rieneke T. Lugtenberg, Stefanie de Groot, Danny Houtsma, Vincent O. Dezentjé, Annelie J. E. Vulink, Maarten J. Fischer, Johanneke E. A. Portielje, Jacobus J. M. van der Hoeven, Hans Gelderblom, Hanno Pijl et al.
Cancers 2023, 15(6), 1691; https://doi.org/10.3390/cancers15061691
Available online: https://www.mdpi.com/2072-6694/15/6/1691
| “Bone and Soft Tissue Tumors: Molecular Mechanisms, Clinical Practice, and Emerging Therapeutics” Edited by Prof. Dr. Toshihiro Akisue, Dr. Shintaro Iwata and Dr. Toru Akiyama Submission deadline: 31 May 2024 |
“The Evolving Treatment and Clinical Trials of Hepatocellular Carcinoma” Edited by Dr. Zachary J. Brown and Dr. John D. Allendorf Submission deadline: 31 May 2024 |
 |
 |
| “Clinical Outcomes in Urologic Cancers” Edited by Dr. Simone Morra and Prof. Dr. Pierre Karakiewicz Submission deadline: 30 June 2024 |
“Prognostic Factors in Urologic Cancers—Assessment and Integration into Clinical Care“ Edited by Prof. Dr. Maximilian Burger and Prof. Dr. Christian Thomas Submission deadline: 30 June 2024 |
 |
 |
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
19 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Tumor Microenvironment
We are delighted to share some highly viewed papers on tumor microenvironment that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:
“Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the ‘NSCLC’ of GI Oncology?”
by Amol Gupta, Razelle Kurzrock and Jacob J. Adashek
Cancers 2023, 15(5), 1578; https://doi.org/10.3390/cancers15051578
Available online: https://www.mdpi.com/2072-6694/15/5/1578
“Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer”
by Samradhi Singh, Poonam Sharma, Devojit Kumar Sarma, Manoj Kumawat, Rajnarayan Tiwari, Vinod Verma, Ravinder Nagpal and Manoj Kumar
Cancers 2023, 15(6), 1913; https://doi.org/10.3390/cancers15061913
Available online: https://www.mdpi.com/2072-6694/15/6/1913
“The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome”
by Kazutoshi Fujita, Makoto Matsushita, Marco A. De Velasco, Koji Hatano, Takafumi Minami, Norio Nonomura and Hirotsugu Uemura
Cancers 2023, 15(5), 1375; https://doi.org/10.3390/cancers15051375
Available online: https://www.mdpi.com/2072-6694/15/5/1375
“Brain Tumor Detection Based on Deep Learning Approaches and Magnetic Resonance Imaging”
by Akmalbek Bobomirzaevich Abdusalomov, Mukhriddin Mukhiddinov and Taeg Keun Whangbo
Cancers 2023, 15(16), 4172; https://doi.org/10.3390/cancers15164172
Available online: https://www.mdpi.com/2072-6694/15/16/4172
“Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response”
by Marylène Lejeune, Laia Reverté, Esther Sauras, Noèlia Gallardo, Ramon Bosch, Albert Roso, Anna Petit, Vicente Peg, Francisco Riu, Joan García-Fontgivell et al.
Cancers 2023, 15(3), 597; https://doi.org/10.3390/cancers15030597
Available online: https://www.mdpi.com/2072-6694/15/3/597
“The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer”
by Pariyada Tanjak, Amphun Chaiboonchoe, Tharathorn Suwatthanarak, Onchira Acharayothin, Kullanist Thanormjit, Jantappapa Chanthercrob, Thanawat Suwatthanarak, Bundit Wannasuphaphol, Kemmapon Chumchuen, Bhoom Suktitipat et al.
Cancers 2023, 15(4), 1098; https://doi.org/10.3390/cancers15041098
Available online: https://www.mdpi.com/2072-6694/15/4/1098
 |
“Targeting Signal Transduction Pathways in Cancer” Edited by Dr. Mohd W. Nasser, Prof. Dr. Shahab Uddin, Prof. Dr. Klaus Podar and Dr. Martin Sattler Submission deadline: 31 March 2024 |
 |
“Tumor Microenvironment in Primary Liver Cancer” Edited by Dr. Stefania Mantovani and Dr. Barbara Oliviero Submission deadline: 28 June 2024 |
 |
“Unique Perspectives in Cancer Signaling” Edited by Dr. Peiwen Fei Submission deadline: 15 September 2024 |
 |
“Tumor-Associated Microenvironments and Inflammation” Edited by Prof. Dr. Ren Xu and Prof. Dr. Bing Li Submission deadline: 15 April 2024 |
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
19 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Methods and Technologies Development
We are delighted to share some highly viewed papers on methods and technologies development that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:
“18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?”
by Domenico Albano, Giorgio Treglia, Francesco Dondi, Anna Calabrò, Alessio Rizzo, Salvatore Annunziata, Luca Guerra, Silvia Morbelli, Alessandra Tucci and Francesco Bertagna
Cancers 2023, 15(9), 2494; https://doi.org/10.3390/cancers15092494
Available online: https://www.mdpi.com/2072-6694/15/9/2494
“Role of PET/CT in Oropharyngeal Cancers”
by Emily W. Avery, Kavita Joshi, Saral Mehra and Amit Mahajan
Cancers 2023, 15(9), 2651; https://doi.org/10.3390/cancers15092651
Available online: https://www.mdpi.com/2072-6694/15/9/2651
“Artificial Intelligence in CT and MR Imaging for Oncological Applications”
by Ramesh Paudyal, Akash D. Shah, Oguz Akin, Richard K. G. Do, Amaresha Shridhar Konar, Vaios Hatzoglou, Usman Mahmood, Nancy Lee, Richard J. Wong, Suchandrima Banerjee et al.
Cancers 2023, 15(9), 2573; https://doi.org/10.3390/cancers15092573
Available online: https://www.mdpi.com/2072-6694/15/9/2573
“See Lung Cancer with an AI”
by Joanna Bidzińska and Edyta Szurowska
Cancers 2023, 15(4), 1321; https://doi.org/10.3390/cancers15041321
Available online: https://www.mdpi.com/2072-6694/15/4/1321
“Multimodal Deep Learning-Based Prognostication in Glioma Patients: A Systematic Review”
by Kaitlyn Alleman, Erik Knecht, Jonathan Huang, Lu Zhang, Sandi Lam and Michael DeCuypere
Cancers 2023, 15(2), 545; https://doi.org/10.3390/cancers15020545
Available online: https://www.mdpi.com/2072-6694/15/2/545
“Long Axial Field-of-View PET/CT Could Answer Unmet Needs in Gynecological Cancers”
by Elizabeth Katherine Anna Triumbari, Vittoria Rufini, Clemens Mingels, Axel Rominger, Abass Alavi, Francesco Fanfani, Ramsey D. Badawi and Lorenzo Nardo
Cancers 2023, 15(9), 2407; https://doi.org/10.3390/cancers15092407
Available online: https://www.mdpi.com/2072-6694/15/9/2407
 |
|
| “The Role of PET Imaging in Oncology: New Advancements in Clinical and Research Setting” Edited by Dr. Pierpaolo Alongi and Dr. Desiree Deandreis Submission deadline: 31 March 2024 |
“Artificial Intelligence and Machine Learning in Precision Oncology” Edited by Dr. Carmen Belli and Dr. Santosh Anand Submission deadline: 30 April 2024 |
 |
 |
| “Recent Trends in PET/CT Tracer Development and Multimodal Imaging” Edited by Prof. Dr. Olaf Prante and Prof. Dr. Tobias Bäuerle Submission deadline: 30 June 2024 |
“Radionuclide Therapy and Hybrid Imaging in Oncology” Edited by Dr. Amir Sabet and Prof. Dr. Frank Grünwald Submission deadline: 29 February 2024 |
 |
 |
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
7 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Biomarkers in 2023
We are delighted to share some highly viewed papers on cancer biomarkers that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.
The list of relevant papers can be seen below:
“Effect of Selenium and Lycopene on Radiation Sensitivity in Prostate Cancer Patients Relative to Controls”
by Varinderpal S. Dhillon, Permal Deo and Michael Fenech
Cancers 2023, 15(3), 979; https://doi.org/10.3390/cancers15030979
Available online: https://www.mdpi.com/2072-6694/15/3/979
“Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors”
by Yasuyuki Matsumoto and Tongzhong Ju
Cancers 2023, 15(14), 3536; https://doi.org/10.3390/cancers15143536
Available online: https://www.mdpi.com/2072-6694/15/14/3536
“Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1”
by Jessica M. Logan, Ashley M. Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R. D. Johnson, Shane M. Hickey, Ben S.-Y. Ung et al.
Cancers 2023, 15(12), 3215; https://doi.org/10.3390/cancers15123215
Available online: https://www.mdpi.com/2072-6694/15/12/3215
“Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Biological Data”
by Katrin S. Kurz, Sabrina Kalmbach, Michaela Ott, Annette M. Staiger, German Ott and Heike Horn
Cancers 2023, 15(3), 785; https://doi.org/10.3390/cancers15030785
Available online: https://www.mdpi.com/2072-6694/15/3/785
“Mucins as Potential Biomarkers for Early Detection of Cancer”
by Shailendra K. Gautam, Parvez Khan, Gopalakrishnan Natarajan, Pranita Atri, Abhijit Aithal, Apar K. Ganti, Surinder K. Batra, Mohd W. Nasser and Maneesh Jain
Cancers 2023, 15(6), 1640; https://doi.org/10.3390/cancers15061640
Available online: https://www.mdpi.com/2072-6694/15/6/1640
“LC-MS/MS Based Volatile Organic Compound Biomarkers Analysis for Early Detection of Lung Cancer”
by Shuaibu Nazifi Sani, Wei Zhou, Balarabe B. Ismail, Yongkui Zhang, Zhijun Chen, Binjie Zhang, Changqian Bao, Houde Zhang and Xiaozhi Wang
Cancers 2023, 15(4), 1186; https://doi.org/10.3390/cancers15041186
Available online: https://www.mdpi.com/2072-6694/15/4/1186
 |
|
| “Head and Neck Cancers—Novel Approaches and Future Outlook” Edited by Dr. Claudia Maletzki Submission deadline: 31 October 2024 |
“Feature Papers in Section "Cancer Biomarkers" in 2023–2024” Edited by Prof. Dr. Maxim V. Berezovski Submission deadline: 31 May 2024 |
|
|
|
| “Advances in Soft Tissue and Bone Sarcoma” Edited by Dr. Catrin Sian Rutland Submission deadline: 30 April 2024 |
“Liquid Biopsy for Lung Cancer Treatment” Edited by Dr. Maria Palmieri and Dr. Frullanti Elisa Submission deadline: 30 July 2024 |
|
|
|
| “PTEN: Regulation, Signalling and Targeting in Cancer” Edited by Dr. Mark G.H. Scott, Dr. Larissa Kotelevets and Dr. Éric Chastre Submission deadline: 31 December 2024 |
“Genome Sequencing of Cancer: Identifying Targets and Biomarkers for Therapy” Edited by Dr. Haruhiko Takeda Submission deadline: 25 October 2024 |
|
|
|
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
6 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Immunology and Immunotherapy
We are delighted to share some highly viewed papers on cancer immunology and immunotherapy that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.
“Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment”
by Dimitrios C. Ziogas, Charalampos Theocharopoulos, Panagiotis-Petros Lialios, Dimitra Foteinou, Ioannis-Alexios Koumprentziotis, Georgios Xynos and Helen Gogas
Cancers 2023, 15(10), 2718; https://doi.org/10.3390/cancers15102718
Available online: https://www.mdpi.com/2072-6694/15/10/2718
“Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events”
by Iñigo Les, Mireia Martínez, Inés Pérez-Francisco, María Cabero, Lucía Teijeira, Virginia Arrazubi, Nuria Torrego, Ana Campillo-Calatayud, Iñaki Elejalde, Grazyna Kochan et al.
Cancers 2023, 15(5), 1629; https://doi.org/10.3390/cancers15051629
Available online: https://www.mdpi.com/2072-6694/15/5/1629
“Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes”
by Mefotse Saha Cyrelle Ornella, Narayanasamy Badrinath, Kyeong-Ae Kim, Jung Hee Kim, Euna Cho, Tae-Ho Hwang and Jae-Joon Kim
Cancers 2023, 15(8), 2383; https://doi.org/10.3390/cancers15082383
Available online: https://www.mdpi.com/2072-6694/15/8/2383
“Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma”
by Tatsuya Deguchi, Naoya Maekawa, Satoru Konnai, Ryo Owaki, Kenji Hosoya, Keitaro Morishita, Motoji Nakamura, Tomohiro Okagawa, Hiroto Takeuchi, Sangho Kim et al.
Cancers 2023, 15(11), 3013; https://doi.org/10.3390/cancers15113013
Available online: https://www.mdpi.com/2072-6694/15/11/3013
“Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis”
by Melissa M. De Meza, Willeke A. M. Blokx, Johannes J. Bonenkamp, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Jan Willem B. De Groot, John B. A. G. Haanen, Geke A. P. Hospers et al.
Cancers 2023, 15(2), 409; https://doi.org/10.3390/cancers15020409
Available online: https://www.mdpi.com/2072-6694/15/2/409
“Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma”
by Gitanjali Sharma, Marta C. Braga, Chiara Da Pieve, Wojciech Szopa, Tatjana Starzetz, Karl H. Plate, Wojciech Kaspera and Gabriela Kramer-Marek
Cancers 2023, 15(12), 3131; https://doi.org/10.3390/cancers15123131
Available online: https://www.mdpi.com/2072-6694/15/12/3131
| “Anticancer Immunity with Physical Treatment Modalities” Edited by Dr. Sander Bekeschus Submission deadline: 1 June 2024 Available online: https://www.mdpi.com/journal/cancers/special_issues/GWHKI53P66 |
“Cancer and Immunomediated Inflammatory Diseases (IMIDs)” Edited by Prof. Dr. Sandro Ardizzone Submission deadline: 10 June 2024 Available online: https://www.mdpi.com/journal/cancers/special_issues/D63VX78S95 |
|
|
|
| “The Tumor Microenvironment and Molecular Aberrations Convey Immune Evasion (Volume II)” Edited by Prof. Dr. Razelle Kurzrock, Dr. Anwaar Saeed, Dr. Linlin Guo and Dr. Ludimila Cavalcante Submission deadline: 20 June 2024 Available online: https://www.mdpi.com/journal/cancers/special_issues/4BPEBEU010 |
“Immune Checkpoint Inhibitors for Urologic Cancers” Edited by Dr. Panagiotis Vlachostergios Submission deadline: 30 June 2024 Available online: https://www.mdpi.com/journal/cancers/special_issues/9LF513VT85 |
|
|
|
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
2 February 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Drug Development”
1 February 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Immunology and Immunotherapy”
31 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Pathophysiology”
31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI and Digital Science Meeting
At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.
As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.
Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.
During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.
What is Altmetric?
You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.
Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.
“Almetric provides visual insights into where research is being discussed”
Sources Tracked by Altmetric
Altmetric badge showing the Altmetric score and colour-coded mention sources.
Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.
The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.
Read more:
Impactful Research
Ten High-Altmetric Articles Published by MDPI
As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.
So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.
Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.
|
|
“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort” J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003 Altmetric page: https://mdpi.altmetric.com/details/20477344 Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News. |
|
|
“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis” J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404 Altmetric page: https://mdpi.altmetric.com/details/57654628 Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times. |
|
|
“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia” Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024 Altmetric page: https://mdpi.altmetric.com/details/111086701 Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic. |
|
|
“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability” Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007 Altmetric page: https://mdpi.altmetric.com/details/83796184 Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian. |
|
|
“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study” Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933 Altmetric page: https://mdpi.altmetric.com/details/133463915 Altmetric shows that this article appeared in 192 news stories from 186 outlets. |
How do I use altmetrics?
Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.
Sharing Research Online
For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.
|
|
“An Update on Eukaryotic Viruses Revived from Ancient Permafrost” Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564 Altmetric page: https://mdpi.altmetric.com/details/142929875 Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN. |
|
|
“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications” Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001 Altmetric page: https://mdpi.altmetric.com/details/53406248 Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes. |
|
|
“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health” Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212 Altmetric page: https://mdpi.altmetric.com/details/86529137 Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum. |
|
|
“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health” Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431 Altmetric page: https://mdpi.altmetric.com/details/34714141 Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review. |
|
|
“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens” Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590 Altmetric page: https://mdpi.altmetric.com/details/142934305 Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC. |
Inside MDPI
MDPI Annual Meeting Celebrations in China
On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.
The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.
“It is essential that we stay connected and share best practices”
I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.
Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.
Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.
The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.
I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!
Coming Together for Science
MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership
We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.
“This initiative reflects our dedication to transparent and inclusive publishing”
TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.
For further details on our Institutional Open Access Program (IOAP), please contact us.
Benefits to MDPI’s IOAP
At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.
For further information, see our IOAP FAQ.
Closing Thoughts
Reflections on the 2024 APE Conference
MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.
The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.
“It's fascinating to see how other publishers are leveraging AI”
Highlights
Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.
In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.
“We can share best practices and lessons learned”
Incorporating MDPI’s Insights into Conferences
I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.
Chief Executive Officer
MDPI AG
